Alvotech has brought in public markets specialist Tanya Zharov as deputy CEO for the firm in Iceland, as it prepares for a public listing.

Sandoz has named Peter Stenico as permanent country head for its German operations. At the same time, Stada has appointed a trio of executives to key roles in Germany, Hovione has announced a new COO, Hikma and Orion have seen board changes and Sanofi’s biosimilars head in China has left the position for a new role.

ANI revealed last month that long-serving company head Arthur Przybyl would be departing after 11 years at the top. The US-based player has just announced its interim chief as it reported first-quarter sales, following the landmark US portfolio acquisition from Amerigen in January, and made a major announcement for its full-year financial guidance.

Teva’s country head for its local Israeli operation has moved on, with Teva promoting his successor from within. Meanwhile, Doug Sommerville, the former head of Teva Canada, has taken a new role dedicated to efforts to tackle the accelerating COVID-19 crisis.

Associated with Mylan since the mid-1990s and formerly serving as CEO for more than a decade, chairman Robert Coury has been appointed to a position of greater influence with the company, as Mylan fights battles on several fronts.

ANI Pharmaceuticals has been steered by former Akorn head Arthur Przybyl since March 2009. But he will bring the curtain down on his time with the company next month, as the company recruits his replacement ahead of a key branded product launch.